Ann N Y Acad Sci. 2009 Sep;1173:829-36.
An open-label study adding creatine monohydrate to ongoing medical regimens in patients with the fibromyalgia syndrome.
Leader A, Amital D, Rubinow A, Amital H. Department of Medicine D, Meir Medical Center, Tel-Aviv University, Kfar Saba, Israel.
Fibromyalgia is an ill-defined condition that causes pain and disability but still lacks effective treatment. The aim of this open-label study was to assess the efficacy of administering a food supplement, creatine monohydrate, in an "add on" to existing therapies in patients with fibromyalgia. This study included 30 patients with fibromyalgia. After 8 weeks of receiving creatine, we witnessed a significant improvement in parameters reflecting severity of fibromyalgia, quality of life and sleep, disability, and pain. These results deteriorated 4 weeks after stopping creatine therapy. The findings of this study are preliminary and limited due to the small sample and relatively high rate of dropouts.
PMID: 19758235 [PubMed - in process]
{mosgoogle}
{mos_sb_discuss:9}
Please Help Support EiR with a Positive Google Review!
If you like EiR and / or enoyed this content; please help us keep going by leaving a Positive Google Review:
Review EiR on Google NOW!
P.S. This is entirely secure, we collect no data other than what is freely available from Google and you can remain anonymous!
Related Articles:
Mold Testing & Sanitizer:
ADVERTISEMENT
